| Abstrakt: |
A recent study conducted in Palestine investigated the relationship between a specific gene polymorphism and the development of proliferative diabetic retinopathy (PDR) in type 2 diabetic patients. The study found that the duration of diabetes and the presence of dyslipidemia were strong indicators for the progression of PDR. However, the gene polymorphism in question, aldose reductase (ALR2) (C106T), was not associated with the severity of diabetic retinopathy. These findings provide valuable insights into the risk factors and genetic factors involved in the development of PDR. [Extracted from the article] |
